πŸ‡ΊπŸ‡Έ FDA
Patent

US 11147790

Treatment of cutaneous disorders

granted A61KA61K31/121A61K31/245

Quick answer

US patent 11147790 (Treatment of cutaneous disorders) held by Verrica Pharmaceuticals Inc. expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Verrica Pharmaceuticals Inc.
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/121, A61K31/245, A61K31/343, A61K9/0014